Related Experiment Videos
[Various mechanisms of heart failure in liver diseases]
Insights
This review covers heart disease in liver cirrhosis, detailing cirrhotic cardiomyopathy pathogenesis and diagnosis. It highlights noninvasive methods like serum markers, echocardiography, and ECG for detecting myocardial fibrosis.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Liver cirrhosis is associated with various heart conditions, collectively termed cirrhotic cardiomyopathy.
- The pathogenesis and diagnosis of cirrhotic cardiomyopathy are complex and vary with the underlying etiology of cirrhosis.
Purpose of the Study:
- To review the literature on heart disease in liver cirrhosis.
- To detail the pathogenesis and diagnostic approaches for cirrhotic cardiomyopathy.
- To present noninvasive methods for diagnosing myocardial fibrosis in cirrhosis.
Main Methods:
- Literature review of studies on heart disease in liver cirrhosis.
- Detailed examination of cirrhotic cardiomyopathy pathogenesis and diagnosis.
- Presentation of noninvasive diagnostic techniques for myocardial fibrosis.
Main Results:
- Cirrhotic cardiomyopathy presents with distinct features regardless of cirrhosis etiology.
- Noninvasive diagnosis of myocardial fibrosis can be achieved using serum fibrosis markers.
- Echocardiography and electrocardiography (ECG) provide quantitative measures of myocardial fibrosis.
Conclusions:
- Understanding cirrhotic cardiomyopathy is crucial for managing patients with liver cirrhosis.
- Noninvasive diagnostic tools offer a promising approach for early detection and management of myocardial fibrosis.
- Further research into noninvasive markers can improve patient outcomes in cirrhotic cardiomyopathy.
Abstract:
The article is a review of the literature on the problem of heart disease in liver cirrhosis of different etiologies (alcohol, amyloidosis, hemochromatosis, viral lesions of the heart). Examined in detail the pathogenesis of cirrhotic cardiomyopathy and diagnosis, occurring in cirrhosis of any etiology. This article presents a noninvasive methods of diagnosis of myocardial fibrosis using serum markers of fibrosis, myocardial fibrosis degree of calculation on the basis of echocardiography and ECG.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.